Cross-cultural adaptation and validation of Leicester Cough Questionnaire in sarcoidosis: the persian version
Main Article Content
Keywords
health-related quality of life, reliability, validity
Abstract
Background and aim: Cough is a common symptom among patients with sarcoidosis, and the Leicester Cough Questionnaire, a cough-specific quality-of-life measure, evaluates the impact of cough across physical, psychological, and social domains in patients with chronic cough. The aim of this study was cross-cultural adaptation and validation of Persian version of Leicester Cough Questionnaire (LCQ) in pulmonary sarcoidosis in Iran. Methods: Psychometric analyses included translation and back translation of the questionnaire, face validity, content validity, construct validity, criterion-related validity, internal consistency, and test –retest reliability were performed. Results: Twenty-five participants demonstrated no major language barriers or difficulties in completing the questionnaire and adequate face validity of ≥1.5. Twelve experts confirmed the content validity was good (CVR˃0.56, I-CVI≤0.79, S-CVI/Ave˃0.80). Totally, 190 patients were included in the study. The Pearson's coefficients and their significance's (P<0.05) showed an acceptable agreement between the LCQ and the SF-36 questionnaire. The goodness-of-fit of the conceptual model including psychological, physical, and social domains, obtained from EFA, was confirmed throughout the RMSEA of 0.09 (<0.1), NFI of 0.9, NNFI of 0.91, and CFI of 0.92 which all were ≥0.9. The Persian LCQ showed an excellent internal consistency regarding Cronbach’s alpha of 0.974 and ICC (95%CI) value of 0.983 (0.977, 0.987). Conclusions: The psychometric properties showed that the Persian version of LCQ is a valid and reliable measure to evaluate cough-specific quality of life and is a fit-for-purpose measure for use in patients with pulmonary sarcoidosis and the results can guide clinicians in treatment decisions.
References
2. Sakthivel P, Bruder D. Mechanism of granuloma formation in sarcoidosis. Curr Opin Hematol. 2017 Jan;24(1):59–65.
3. Ferris R, Maung T, Atkins C, et al. Test-retest repeatability for Fatigue Assessment Scale, Short-Form 6-Dimension and King’s Sarcoidosis Questionnaire in people with sarcoidosis associated fatigue. Sarcoidosis, Vasc Diffus Lung Dis [Internet]. 2023 Sep 13;40(3 SE-Original Articles: Clinical Research):e2023041. Available from: https://www.mattioli1885journals.com/index.php/sarcoidosis/article/view/13253
4. Gvozdenovic BS, Mihailovic-Vucinic V V, Vukovic MH, et al. Predictors of cough-specific and generic quality of life in sarcoidosis patients. Sarcoidosis, Vasc Diffus lung Dis Off J WASOG. 2020;37(2):158–68.
5. Harrison NK. Cough, sarcoidosis and idiopathic pulmonary fibrosis: raw nerves and bad vibrations. Cough. 2013 Mar;9(1):9.
6. Muñoz G, Buxó M, de Gracia J, et al. Validation of a Spanish version of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Chron Respir Dis [Internet]. 2016/02/22. 2016 May;13(2):128–36. Available from: https://pubmed.ncbi.nlm.nih.gov/26902541
7. Berkhof FF, Boom LN, ten Hertog NE, Uil SM, Kerstjens HAM, van den Berg JWK. The validity and precision of the Leicester Cough Questionnaire in COPD patients with chronic cough. Health Qual Life Outcomes. 2012 Jan;10:4.
8. Yousaf N, Lee KK, Jayaraman B, Pavord ID, Birring SS. The assessment of quality of life in acute cough with the Leicester Cough Questionnaire (LCQ-acute). Cough [Internet]. 2011;7(1):4. Available from: doi:10.1186/1745-9974-7-4
9. Ward N, Stiller K, Rowe H, Holland AE. The psychometric properties of the Leicester Cough Questionnaire and Respiratory Symptoms in CF tool in cystic fibrosis: A preliminary study. J Cyst Fibros [Internet]. 2017;16(3):425–32. Available from: https://www.sciencedirect.com/science/article/pii/S1569199316306695
10. Kavas M, Kaymaz S, Aydoğan Eroglu S, Karasu U, Cobankara V, Boga S. Validation of the Turkish Version of the Sarcoidosis Health Questionnaire: A cross-sectional study: Turkish Version of the Sarcoidosis Health Questionnaire. Sarcoidosis, Vasc Diffus Lung Dis [Internet]. 2023 Mar 28;40(1 SE-Original Articles: Clinical Research):e2023002. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/13617
11. Klein R, Judson M, Barkes B, et al. Potential limitations of activity tracking devices in monitoring effects of treatment for sarcoidosis . Sarcoidosis, Vasc Diffus Lung Dis [Internet]. 2023 Mar 28;40(1 SE-Original Articles: Clinical Research):e2023010. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/12395
12. Huisman AN, Wu M-Z, Uil SM, van den Berg JWK. Reliability and validity of a Dutch version of the Leicester Cough Questionnaire. Cough. 2007;3(1):1–5.
13. Kwon JW, Moon JY, Kim SH, et al. Reliability and validity of a korean version of the leicester cough questionnaire. Allergy Asthma Immunol Res. 2015 May;7(3):230-3.
14. Sönnerfors P, Faager G, Einarsson U. Translation of the Leicester Cough Questionnaire into Swedish, and validity and reliability in chronic obstructive pulmonary disease. Disabil Rehabil. 2018;40(22):2662–70.
15. Pornsuriyasak P, Kawamatawong T, Rattanasiri S, et al. Validity and reliability of the Thai version of the leicester cough questionnaire in chronic cough. Asian Pacific J Allergy Immunol. 2016;34(3):212–6.
16. Dąbrowska M, Krakowiak K, Radlińska O, et al. Validation of the Polish Version of the Chronic Cough Quality of Life Questionnaire (Leicester Cough Questionnaire). Adv Clin Exp Med [Internet]. 2016;25(4):649–53. Available from: http://europepmc.org/abstract/MED/27629838
17. Munro BH. Statistical Methods for Health Care Research.
18. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MDL, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003 Apr;58(4):339–43.
19. Nguyen AM, Schelfhout J, Muccino D, et al. Leicester Cough Questionnaire validation and clinically important thresholds for change in refractory or unexplained chronic cough. Ther Adv Respir Dis [Internet]. 2022 Jan 1;16:17534666221099736. Available from: https://doi.org/10.1177/17534666221099737
20. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res. 2005 Apr;14(3):875-82.
21. WHODAS 2.0 TRANSLATION PACKAGE (VERSION 1.0).
22. Lawshe CH. A quantitative approach to content validity. Pers Psychol. 1975;28(4):563–75.
23. Plichta SB, Kelvin EA. Munro’s statistical methods for health care research. 2013.
24. Tilden VP, Nelson CA, May BA. Use of qualitative methods to enhance content validity. Nurs Res. 1990;39(3):172–5.
25. Polit DF, Beck CT. The content validity index: are you sure you know what’s being reported? Critique and recommendations. Res Nurs Health. 2006 Oct;29(5):489–97.
26. Lynn MR. Determination and quantification of content validity. Nurs Res. 1986;35(6):382–5.
27. Terwee CB, Prinsen CAC, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual life Res an Int J Qual life Asp Treat care Rehabil. 2018 May;27(5):1159–70.
28. Zamanzadeh V, Rassouli M, Abbaszadeh A, Alavi Majd H, Nikanfar A, Ghahramanian A. Details of content validity and objectifying it in instrument development. NPT. 2015;1(3):163-171.
29. Cortina JM. What Is Coefficient Alpha? An Examination of Theory and Applications. Journal of Applied Psychology, 78, 98-104. 1993;
30. Coster W, Bedell G, Law M, et al. Psychometric evaluation of the Participation and Environment Measure for Children and Youth. Dev Med Child Neurol. 2011 Nov;53(11):1030–7.
31. Lim LL, Seubsman SA, Sleigh A. Thai SF-36 health survey: tests of data quality, scaling assumptions, reliability and validity in healthy men and women. Health Qual Life Outcomes. 2008 Jul 18;6:52.
32. Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–63.
33. Sharma R, Guleria R, Mohan A, Das C. Scadding Criteria for Diagnosis of Sarcoidosis: Is There A Need For Change? Chest 2004 Oct 1;126(4):754S.
34. Dabrowska M, Krakowiak K, Radlińska O, et al. Validation of the Polish Version of the Chronic Cough Quality of Life Questionnaire (Leicester Cough Questionnaire). Adv Clin Exp Med. 2016 Jul 1;25:649–53.
35. Polley L, Yaman N, Heaney L, et al. Impact of cough across different chronic respiratory diseases: comparison of two cough-specific health-related quality of life questionnaires. Chest. 2008;134(2):295–302.
36. French CT, Irwin RS, Fletcher KE, Adams TM. Evaluation of a cough-specific quality-of-life questionnaire. Chest. 2002 Apr;121(4):1123–31.
37. Group TE. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy (New York). 1990;16(3):199–208.
38. Haukeland-Parker S, Hasvik E, Jelsness-Jørgensen L-P, Birring S, Johannessen HH. Cross-cultural adaptation and validation of the Norwegian version of the Leicester Cough Questionnaire in chronic obstructive pulmonary disease. Physiother Theory Pract. 2022 Dec 2;38(12):2175–84.
39. Reychler G, Schinckus M, Fremault A, Liistro G, Pieters T. Validation of the French version of the Leicester Cough Questionnaire in chronic obstructive pulmonary disease. Chron Respir Dis. 2015 Sep 7;12(4):313–9. A
40. Kwon JW, Moon JY, Kim SH, et al. Reliability and validity of a korean version of the leicester cough questionnaire. Allergy Asthma Immunol Res. 2015 May;7(3):230–3.
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Amir Behnam kharazmi, Department of Internal Medicine, Emam Hossein Medical Center, Shahid Beheshti University of Medical Science, Tehran, Iran
ِDr Amir Behnam Kharazmi is also a corresponding author, but I can not mark him on the website as the second corresponding author.
How to Cite
